Fidelity European Trust continued rise as shares advanced in ASML and AIB

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for September 2025.

Portfolio Manager Commentary

European equities ended the quarter higher but underperformed global markets amid ongoing trade tensions and political uncertainty.  

The Trust underperformed the index during the month. Stock picking within financials and industrials weighed on returns, as did the use of gearing.   Shares in Swiss packaging company SIG declined following a profit warning and the announcement of a dividend pause for 2025. Financial intermediary business Deutsche Börse weakened amid a more demanding comparison base in the coming quarters after exceptionally strong trading volumes in 2024 and early 2025. Net interest income has also come under pressure, driven by lower US interest rates, a softening Euribor, and a weaker US dollar. Conversely, shares in ASML gained support following a sentiment shift and bullish analyst upgrades. The company also announced a strategic partnership with France-based Mistral AI. The holding in Irish banking group AIB advanced, tracking the broader strength within the European banking sector. 

Our focus is on finding attractively valued companies with good prospects for cash generation and dividend growth over the longer term. On a rolling 12-month basis, the Trust recorded NAV and share price returns of 5.1% and 7.8% respectively, compared to FTSE World Europe ex UK Total Return Index that returned 15.5%. 

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Are European equities set for a revival?

Marcel Stötzel, Co-Portfolio Manager of Fidelity European Trust, remains positive on Europe’s investment outlook, citing structural reforms, rising defence spending and potential economic integration as key drivers.

Fidelity European Trust continued rise as shares advanced in ASML and AIB

Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance.

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term.

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

Search

Search